26 December 2023
On 26 December 2024, the National Development and Reform Commission and the Ministry of Commerce and the State Administration for Market Regulation issued the “Opinions on Supporting Guangzhou Nansha in Relaxing Market Access and Strengthening Reform of Regulatory System” (“the Opinions”). The Opinions proposed to allow the qualified HK and Macao enterprises to utilize domestic human genetic resources to conduct medical research other than human stem cell and gene diagnosis and treatment. The Opinions also aimed to leverage the role of the evaluation and inspection sub-centre in the Greater Bay Area, explore the ways of undertaking relevant functions, encourage domestic and foreign biomedical and health enterprises and research and development institutions to set up factories in Nansha and develop various products.